Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,666,667
-
Total 13F shares
-
30,000,430
-
Share change
-
+469,896
-
Total reported value
-
$211,439,723
-
Price per share
-
$7.05
-
Number of holders
-
103
-
Value change
-
+$3,365,953
-
Number of buys
-
41
-
Number of sells
-
44
Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q4 2021
As of 31 Dec 2021 HARVARD BIOSCIENCE INC - Common Stock (HBIO) had 103 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 30,000,430 shares of stock of the company.
Largest 10 holders included BlackRock Inc., Portolan Capital Management, LLC, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC., DIMENSIONAL FUND ADVISORS LP, ROYCE & ASSOCIATES LP, VANGUARD GROUP INC, Granahan Investment Management, LLC, Harvey Partners, LLC, ACADIAN ASSET MANAGEMENT LLC, and RENAISSANCE TECHNOLOGIES LLC.
This table shows 103 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.